Advertisement

 

 

Procalcitonin as a diagnostic and prognostic marker in diabetic foot infection. A current literature review.

Procalcitonin as a diagnostic and prognostic marker in diabetic foot infection. A current literature review.
Author Information (click to view)

Velissaris D, Pantzaris ND, Platanaki C, Antonopoulou N, Gogos C,


Velissaris D, Pantzaris ND, Platanaki C, Antonopoulou N, Gogos C, (click to view)

Velissaris D, Pantzaris ND, Platanaki C, Antonopoulou N, Gogos C,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Romanian journal of internal medicine = Revue roumaine de medecine interne 2017 10 11() doi 10.1515/rjim-2017-0039
Abstract

Diabetic foot ulcers (DFUs) are a very common cause of mortality and morbidity. The distinction between infected and non-infected DFU remains a very challenging task for clinicians in everyday practice. Even when infection is documented, the spectrum of diabetic foot infection is wide, ranging from cellulitis and soft tissue infection to osteomyelitis. Procalcitonin (PCT), a well-established sepsis biomarker, has been used in the diagnosis of several infections including osteomyelitis in patients with diabetes mellitus. This review gathers and presents all the relevant data, up until now, regarding the use of PCT as an assessment tool in diabetic patients with foot infection. Current evidence suggests that PCT levels could aid clinicians in distinguishing infected from non-infected DFUs as well as in the distinction between soft tissue infection and bone involvement, but further and larger studies are warranted to confirm these findings.

Submit a Comment

Your email address will not be published. Required fields are marked *

nine + 2 =

[ HIDE/SHOW ]